Skip to main content
TipRanks
Go Ultimate75% OFF

Cypherpunk Technologies (5MC) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Bevacizumab, Folfiri, Folfox, Dkn-01Colorectal Cancer, Colorectal Adenocarcinoma, Colorectal Cancer Metastatic, Colo-Rectal CancerPhase IICompletedPhase 2 Study of DKN-01 in Colorectal CancerJul 21, 2022―
Fluorouracil, Oxaliplatin, Dkn-01 300Mg, Dkn-01 600Mg, Dkn-01 400Mg, Tislelizumab 200Mg, Tislelizumab 400Mg, Capecitabine 1000Mg/ M2 Twice Daily (Bid), Leucovorin CalciumGastroesophageal Cancer, Gastric Cancer, Gastric AdenocarcinomaPhase IITerminatedA Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal CancerApr 23, 2020―
Paclitaxel, 300Mg Dkn-01, 600Mg Dkn-01Ovarian Cancer, Endometrial Cancer, Uterine Cancer, CarcinosarcomaPhase IICompletedA Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or CarcinosarcomaJan 02, 2018―
Trx518 Monotherapy, Trx518 With Gemcitabine, Trx518 With Pembrolizumab, Trx518 With NivolumabSolid TumorsPhase ICompletedPhase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or NivolumabDec 01, 2015―
Gemcitabine, Cisplatin, Dkn-01Bile Duct Cancer, Cholangiocarcinoma, Carcinoma Of Intrahepatic And Extra-Hepatic Biliary System, Carcinoma Of GallbladderPhase ICompletedStudy of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or GallbladderFeb 18, 2015―
Pembrolizumab, Paclitaxel, Dkn-01 150 Mg, Dkn-01 300 MgGastroesophageal Cancer, Gastric Adenocarcinoma, Squamous Cell Carcinoma, Adenocarcinoma Of The Gastroesophageal Junction, Esophageal NeoplasmsPhase ICompletedA Study of DKN-01 in Combination With Paclitaxel or PembrolizumabDec 11, 2013―
Standard of Care, Dkn-01 300 Mg, Dkn-01 600 MgMultiple MyelomaPhase ICompletedA Study of DKN-01 and Lenalidomide/Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaOct 18, 2012―
Trx518Unresectable Stage Iii Or Stage Iv Malignant Melanoma Or Other Solid Tumor MalignanciesPhase ICompletedTrial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid TumorsNov 09, 2010―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cypherpunk Technologies Inc. (DE:5MC) have in its pipeline
Cypherpunk Technologies DE:5MC is currently developing the following drugs: Bevacizumab, Folfiri, Folfox, Dkn-01, Fluorouracil, Oxaliplatin, Dkn-01 300Mg, Dkn-01 600Mg, Dkn-01 400Mg, Tislelizumab 200Mg, Tislelizumab 400Mg, Capecitabine 1000Mg/ M2 Twice Daily (Bid), Leucovorin Calcium, Paclitaxel, 300Mg Dkn-01, 600Mg Dkn-01, Trx518 Monotherapy, Trx518 With Gemcitabine, Trx518 With Pembrolizumab, Trx518 With Nivolumab, Gemcitabine, Cisplatin, Dkn-01, Pembrolizumab, Paclitaxel, Dkn-01 150 Mg, Dkn-01 300 Mg, Standard of Care, Dkn-01 300 Mg, Dkn-01 600 Mg, Trx518. These drug candidates are in various stages of clinical development as the company works toward FDA approval.